Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (6) , 1275-1283
- https://doi.org/10.1111/j.0022-202x.2005.23735.x
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- The Transcription Factors c-rel and RelA Control Epidermal Development and Homeostasis in Embryonic and Adult Skin via Distinct MechanismsMolecular and Cellular Biology, 2004
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- NF-κB determines localization and features of cell death in epidermisJournal of Clinical Investigation, 2000
- Role of NF-κB in the Apoptotic-resistant Phenotype of KeratinocytesJournal of Biological Chemistry, 1999
- Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300Molecular Cell, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent MechanismCell, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Interaction of the COOH-terminal Transactivation Domain of p65 NF-κB with TATA-binding Protein, Transcription Factor IIB, and CoactivatorsPublished by Elsevier ,1995
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994